Transcription of VUMC INTRAVENOUS MEDICATION …
{{id}} {{{paragraph}}}
VUMC INTRAVENOUS MEDICATION administration CHARTA pproved by Pharmacy and Therapeutics Committee, Revised October 2014*INFUSION CONCENTRATIONICUStep DownGen CareStandard (Std)Maximum (Max)Adenosine(Adenocard)AntiarrythmicXM D presentXMD presentXMD present6 mg / 2 mLInfusion not recommended AlbuminBlood Product DerivativeXXXNot for IV Push5% or 25%Alemtuzumab (Campath)Monoclonal AntibodyXXXNot for IV Push30 mg / 100 mLAlprostadil(Prostin VR)ProstaglandinXGRPeds:20 mcg/mLAlteplaseTissue Plasminogen Activator (t-PA)(Activase)ThrombolyticXXNo titration of infusion1 mg/mLAdult:100 mg / 100 mLPeds: 1 mg/mLAminocaproic Acid(Amicar)Hemostatic AgentXNot for IV PushAdult:20 Gm / 250 mLPeds: 20 mcg/mL* Refer to references such as Mosby s for additional information on administration and monitoring. Alternate infusion rates permitted at provider discretion.** Central Line Preferred indicates that the MEDICATION is associated with venous irritation.
* Refer to references such as Mosby’s for additional information on administration and monitoring. Alternate infusion rates permitted at provider discretion.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}